Bb5a31f81Topic
Clinical trial data over two years showed patients receiving Merck and Moderna's experimental melanoma vaccine were 42 percent less likely to experience cancer recurrence compared to patients who did not receive the vaccine
Bb5a31f81Topic
552c7ae14Topic
Cancer & Oncology
Cancer treatment, oncology drug access, hematologic malignancies, and cancer drug policy.
225 claims·158 news stories